Luke M. Beshar, Director at REGENXBIO Inc. (RGNX), sold 65,384 shares at $60.38 ($3.9M) on 2018-11-20, disclosed to the SEC on 2018-11-21.
Open-market sale of $3.9M RGNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.26 | 10,916 | $658K | 16.7% |
| 2 | $60.26 | 10,916 | $658K | 16.7% |
| 3 | $62.81 | 600 | $38K | 1.0% |
| 4 | $63.53 | 600 | $38K | 1.0% |
| 5 | $60.38 | 21,176 | $1.3M | 32.4% |
| 6 | $60.38 | 21,176 |
| $1.3M |
| 32.4% |
| Total | $60.39 avg | 65,384 | $3.9M | 100% |
| Filing → |
| TARA | BUY | 2022-03-14 | $45K | — | Filing → |
| RGNX | SELL | 2018-12-03 | $831K | — | Filing → |
| RGNX | SELL | 2018-11-28 | $2.6M | — | Filing → |